Tg Therapeutics TGTX
NASDAQ TGTX
$56.83 +0.65 (+1.15%)
As of: Sep 30, 2026 · 2:36 PM EDT

Tg Therapeutics (TGTX) Current Assets (2010 - 2026)

Updated

Tg Therapeutics (TGTX) recorded Current Assets of $1.15 billion in Q2 2026, up 72.6% from $663.96 million a year earlier and up 5.4% from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Tg Therapeutics reported Current Assets of $630.76 million, up 11.4% from FY2024.

  • Annual Current Assets has increased for three straight years, with a five-year compound annual growth rate of 0.6% (FY2020 to FY2025).
  • Across earlier years, Current Assets came in at $566.36 million in FY2024 (+78.1%), $317.94 million in FY2023 (+88.9%), $168.27 million in FY2022 (-49.2%) and $330.97 million in FY2021 (-45.9%).
  • The Q2 2026 figure is the highest quarterly Current Assets in data going back to Q4 2010.
  • On a year-over-year basis, Current Assets has increased for 13 consecutive quarters, with growth averaging 58.1% over the last eight quarters.
  • Peak year-over-year performance for Current Assets in the last five years was growth of 95.1% in Q1 2024, against a decline of 55.5% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.09 billion (Q1 2026), $630.76 million (Q4 2025) and $599.77 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 59.77 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.67 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 27.97 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 12.54 Bn
10 Tg Therapeutics 8.60 Bn 7.99 Bn 199.14 Mn 1.15 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.15 Bn
Mar 31, 2026 1.09 Bn
Dec 31, 2025 630.76 Mn
Sep 30, 2025 599.77 Mn
Jun 30, 2025 663.96 Mn
Mar 31, 2025 644.51 Mn
Dec 31, 2024 566.36 Mn
Sep 30, 2024 574.07 Mn
Jun 30, 2024 389.15 Mn
Mar 31, 2024 360.58 Mn
Dec 31, 2023 317.94 Mn
Sep 30, 2023 319.11 Mn
Jun 30, 2023 208.57 Mn
Mar 31, 2023 184.78 Mn
Dec 31, 2022 168.27 Mn
Sep 30, 2022 182.92 Mn
Jun 30, 2022 202.56 Mn
Mar 31, 2022 242.22 Mn
Dec 31, 2021 330.97 Mn
Sep 30, 2021 371.78 Mn
API Access

Tg Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=TGTX&period=max&api_key=YOUR_API_KEY